Calidi Biotherapeutics, Inc. (CLDI)

Operating Expenses

$17.43M

TTM · Period ending: · USD

CLDI logo

CLDI Operating Expenses

Latest reported$17.43M
CLDI TTM Operating Expenses ($11.53M → $17.43M)
High-resolution chart · PNG

CLDI operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Calidi Biotherapeutics, Inc. Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
17,425,000
18,939,000
20,240,000
19,407,000
19,585,000
19,693,000
21,009,000
26,832,000
28,727,000
29,492,000
28,528,000
23,760,000
23,625,000
21,470,000
23,159,000
21,791,000
15,899,880
11,527,880
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.